Form 8-K - Current report:
SEC Accession No. 0001193125-21-114744
Filing Date
2021-04-13
Accepted
2021-04-13 16:36:59
Documents
3
Period of Report
2021-04-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d131400d8k.htm 8-K 21627
2 EX-3.1 d131400dex31.htm EX-3.1 24864
3 EX-3.2 d131400dex32.htm EX-3.2 121157
  Complete submission text file 0001193125-21-114744.txt   168805
Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 21823434
SIC: 2834 Pharmaceutical Preparations